416 related articles for article (PubMed ID: 29153879)
1. Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics.
Chen Q; Liu G; Liu S; Su H; Wang Y; Li J; Luo C
Trends Pharmacol Sci; 2018 Jan; 39(1):59-74. PubMed ID: 29153879
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles designed to regulate tumor microenvironment for cancer therapy.
Li M; Zhang F; Su Y; Zhou J; Wang W
Life Sci; 2018 May; 201():37-44. PubMed ID: 29577880
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
Muntimadugu E; Kommineni N; Khan W
Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy.
Yang S; Gao H
Pharmacol Res; 2017 Dec; 126():97-108. PubMed ID: 28501517
[TBL] [Abstract][Full Text] [Related]
5. Tumor Microenvironment-Enabled Nanotherapy.
Wang L; Huo M; Chen Y; Shi J
Adv Healthc Mater; 2018 Apr; 7(8):e1701156. PubMed ID: 29283221
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticles Targeting and Remodeling Tumor Microenvironment for Cancer Theranostics.
Lin G; Chen S; Mi P
J Biomed Nanotechnol; 2018 Jul; 14(7):1189-1207. PubMed ID: 29944095
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment.
Kanapathipillai M; Brock A; Ingber DE
Adv Drug Deliv Rev; 2014 Dec; 79-80():107-18. PubMed ID: 24819216
[TBL] [Abstract][Full Text] [Related]
8. Improved Targeting of Cancers with Nanotherapeutics.
Foster C; Watson A; Kaplinsky J; Kamaly N
Methods Mol Biol; 2017; 1530():13-37. PubMed ID: 28150194
[TBL] [Abstract][Full Text] [Related]
9. Complex interplay between tumor microenvironment and cancer therapy.
Shen M; Kang Y
Front Med; 2018 Aug; 12(4):426-439. PubMed ID: 30097962
[TBL] [Abstract][Full Text] [Related]
10. Responsive and activable nanomedicines for remodeling the tumor microenvironment.
Zhang Y; Han X; Nie G
Nat Protoc; 2021 Jan; 16(1):405-430. PubMed ID: 33311713
[TBL] [Abstract][Full Text] [Related]
11. Insights into the role of components of the tumor microenvironment in oral carcinoma call for new therapeutic approaches.
Salo T; Vered M; Bello IO; Nyberg P; Bitu CC; Zlotogorski Hurvitz A; Dayan D
Exp Cell Res; 2014 Jul; 325(2):58-64. PubMed ID: 24462456
[TBL] [Abstract][Full Text] [Related]
12. A Review of Pharmacological Treatment Options for Lung Cancer: Emphasis on Novel Nanotherapeutics and Associated Toxicity.
England CG; Ng CF; van Berkel V; Frieboes HB
Curr Drug Targets; 2015; 16(10):1057-87. PubMed ID: 25944016
[TBL] [Abstract][Full Text] [Related]
13. Physical oncology: New targets for nanomedicine.
Nicolas-Boluda A; Silva AKA; Fournel S; Gazeau F
Biomaterials; 2018 Jan; 150():87-99. PubMed ID: 29035739
[TBL] [Abstract][Full Text] [Related]
14. Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles.
Niu Y; Zhu J; Li Y; Shi H; Gong Y; Li R; Huo Q; Ma T; Liu Y
J Control Release; 2018 May; 277():35-47. PubMed ID: 29545106
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.
Dai Y; Xu C; Sun X; Chen X
Chem Soc Rev; 2017 Jun; 46(12):3830-3852. PubMed ID: 28516983
[TBL] [Abstract][Full Text] [Related]
16. Versatility of Cancer Associated Fibroblasts: Commendable Targets for Anti-tumor Therapy.
Khan GJ; Sun L; Khan S; Yuan S; Nongyue H
Curr Drug Targets; 2018; 19(13):1573-1588. PubMed ID: 29468965
[TBL] [Abstract][Full Text] [Related]
17. The Therapeutic Potential of Targeting Tumor Microenvironment in Breast Cancer: Rational Strategies and Recent Progress.
Bahrami A; Hassanian SM; Khazaei M; Hasanzadeh M; Shahidsales S; Maftouh M; Ferns GA; Avan A
J Cell Biochem; 2018 Jan; 119(1):111-122. PubMed ID: 28574616
[TBL] [Abstract][Full Text] [Related]
18. Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system.
Chen B; Dai W; Mei D; Liu T; Li S; He B; He B; Yuan L; Zhang H; Wang X; Zhang Q
J Control Release; 2016 Nov; 241():68-80. PubMed ID: 27641831
[TBL] [Abstract][Full Text] [Related]
19. Tumor heterogeneity and nanoparticle-mediated tumor targeting: the importance of delivery system personalization.
Swetha KL; Roy A
Drug Deliv Transl Res; 2018 Oct; 8(5):1508-1526. PubMed ID: 30128797
[TBL] [Abstract][Full Text] [Related]
20. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
